- Overexpression of sorcin enhances cardiac contractility in vivo and in vitro. Frank, K.F., Bölck, B., Ding, Z., Krause, D., Hattebuhr, N., Malik, A., Brixius, K., Hajjar, R.J., Schrader, J., Schwinger, R.H. J. Mol. Cell. Cardiol. (2005)
- Expression and clinical implications of the soluble drug resistance-related calcium-binding protein (sorcin) gene in leukemia patients. Li, G., Tan, Y., Yang, C., Zhao, C., Zhao, H., Wang, J., Xue, Y., Han, M., Qian, L., Zhao, C. Zhonghua Xue Ye Xue Za Zhi (2002)
- Calcium-dependent translocation of sorcin to membranes: functional relevance in contractile tissue. Meyers, M.B., Zamparelli, C., Verzili, D., Dicker, A.P., Blanck, T.J., Chiancone, E. FEBS Lett. (1995)
- Overexpression of sorcin, a calcium-binding protein, induces a low level of paclitaxel resistance in human ovarian and breast cancer cells. Parekh, H.K., Deng, H.B., Choudhary, K., Houser, S.R., Simpkins, H. Biochem. Pharmacol. (2002)
- Purification, cDNA cloning, and expression of human sorcin in vincristine-resistant HOB1 lymphoma cell lines. Lee, W.P. Arch. Biochem. Biophys. (1996)
- Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study. Fineberg, N.A., Sivakumaran, T., Roberts, A., Gale, T. International clinical psychopharmacology. (2005)
- The pharmacodynamics of ethanol: effects on performance and judgment. Gengo, F.M., Gabos, C., Straley, C., Manning, C. Journal of clinical pharmacology. (1990)
- A multidimensional model for characterizing tobacco dependence. Hudmon, K.S., Marks, J.L., Pomerleau, C.S., Bolt, D.M., Brigham, J., Swan, G.E. Nicotine Tob. Res. (2003)
- A review of 19 double-blind placebo-controlled studies in social anxiety disorder (social phobia). Versiani, M. World J. Biol. Psychiatry (2000)
- Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated. Tolar, M., Marques, M.A., Harmony, J.A., Crutcher, K.A. J. Neurosci. (1997)
- Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Irobi, J., Van Impe, K., Seeman, P., Jordanova, A., Dierick, I., Verpoorten, N., Michalik, A., De Vriendt, E., Jacobs, A., Van Gerwen, V., Vennekens, K., Mazanec, R., Tournev, I., Hilton-Jones, D., Talbot, K., Kremensky, I., Van Den Bosch, L., Robberecht, W., Van Vandekerckhove, J., Broeckhoven, C., Gettemans, J., De Jonghe, P., Timmerman, V. Nat. Genet. (2004)
- Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression. Hsieh, J.J., Cheng, E.H., Korsmeyer, S.J. Cell (2003)
- Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Sereda, M.W., Meyer zu Hörste, G., Suter, U., Uzma, N., Nave, K.A. Nat. Med. (2003)
- Heparin-binding protein targeted to mitochondrial compartments protects endothelial cells from apoptosis. Olofsson, A.M., Vestberg, M., Herwald, H., Rygaard, J., David, G., Arfors, K.E., Linde, V., Flodgaard, H., Dedio, J., Müller-Esterl, W., Lundgren-Akerlund, E. J. Clin. Invest. (1999)
- Modulation of intracellular Ca2+ levels in the heart by sorcin and FKBP12, two accessory proteins of ryanodine receptors. Valdivia, H.H. Trends Pharmacol. Sci. (1998)
- Immunocytochemical identification and localization of the Mr 22,000 calcium-binding protein (sorcin) in an adriamycin-resistant myelogenous leukemia cell line. Sugawara, I., Mizumoto, K., Ohkochi, E., Hamada, H., Tsuruo, T., Mori, S. Jpn. J. Cancer Res. (1989)
- Effect of impaired renal function and haemodialysis on the pharmacokinetics of aprepitant. Bergman, A.J., Marbury, T., Fosbinder, T., Swan, S., Hickey, L., Bradstreet, T.E., Busillo, J., Petty, K.J., Aiyer, K.J., Constanzer, M., Huskey, S.E., Majumdar, A. Clinical pharmacokinetics. (2005)
- Receptor-selective retinoid agonists and teratogenic activity. Willhite, C.C., Dawson, M.I., Reichert, U. Drug Metab. Rev. (1996)
- Preliminary assessment of captopril sonography in screening for renal artery stenosis. Gottlieb, R.H., Lieberman, J.L., Ghaed, V.N., Grossman, E.B., Waldman, D.L., Azodo, M.V., Watt, G.H., Robinette, W.B., Carson, N.L. Academic radiology. (1996)
- Genes amplified and overexpressed in human multidrug-resistant cell lines. Van der Bliek, A.M., Baas, F., Van der Velde-Koerts, T., Biedler, J.L., Meyers, M.B., Ozols, R.F., Hamilton, T.C., Joenje, H., Borst, P. Cancer Res. (1988)
- Calcium-dependent binding of sorcin to the N-terminal domain of synexin (annexin VII). Brownawell, A.M., Creutz, C.E. J. Biol. Chem. (1997)
- Sorcin, an important gene associated with multidrug-resistance in human leukemia cells. Zhou, Y., Xu, Y., Tan, Y., Qi, J., Xiao, Y., Yang, C., Zhu, Z., Xiong, D. Leuk. Res. (2006)
- Presenilin 2 interacts with sorcin, a modulator of the ryanodine receptor. Pack-Chung, E., Meyers, M.B., Pettingell, W.P., Moir, R.D., Brownawell, A.M., Cheng, I., Tanzi, R.E., Kim, T.W. J. Biol. Chem. (2000)
- Peflin and ALG-2, members of the penta-EF-hand protein family, form a heterodimer that dissociates in a Ca2+-dependent manner. Kitaura, Y., Matsumoto, S., Satoh, H., Hitomi, K., Maki, M. J. Biol. Chem. (2001)
- The PEF family proteins sorcin and grancalcin interact in vivo and in vitro. Hansen, C., Tarabykina, S., la Cour, J.M., Lollike, K., Berchtold, M.W. FEBS Lett. (2003)
- Association of sorcin with the cardiac ryanodine receptor. Meyers, M.B., Pickel, V.M., Sheu, S.S., Sharma, V.K., Scotto, K.W., Fishman, G.I. J. Biol. Chem. (1995)
- Association of sorcin with drug resistance in L1210 cells. Roberts, D., Meyers, M.B., Biedler, J.L., Wiggins, L.G. Cancer Chemother. Pharmacol. (1989)
- Sorcin associates with the pore-forming subunit of voltage-dependent L-type Ca2+ channels. Meyers, M.B., Puri, T.S., Chien, A.J., Gao, T., Hsu, P.H., Hosey, M.M., Fishman, G.I. J. Biol. Chem. (1998)
- The scaffolding protein PSD-95 interacts with the glycine transporter GLYT1 and impairs its internalization. Cubelos, B., González-González, I.M., Giménez, C., Zafra, F. J. Neurochem. (2005)
- Effects of polymorphism on the microenvironment of the LDL receptor-binding region of human apoE. Lund-Katz, S., Wehrli, S., Zaiou, M., Newhouse, Y., Weisgraber, K.H., Phillips, M.C. J. Lipid Res. (2001)
- Salmon serum 22 kDa insulin-like growth factor-binding protein (IGFBP) is IGFBP-1. Shimizu, M., Dickey, J.T., Fukada, H., Dickhoff, W.W. J. Endocrinol. (2005)
- Proteinase-3 induces procaspase-3 activation in the absence of apoptosis: potential role of this compartmentalized activation of membrane-associated procaspase-3 in neutrophils. Pederzoli, M., Kantari, C., Gausson, V., Moriceau, S., Witko-Sarsat, V. J. Immunol. (2005)
- The identification and characterization of an epidermal growth factor-stimulated phosphorylation of a specific low molecular weight GTP-binding protein in a reconstituted phospholipid vesicle system. Hart, M.J., Polakis, P.G., Evans, T., Cerione, R.A. J. Biol. Chem. (1990)
- Effects of Clostridium difficile toxin A and toxin B on phospholipase D activation in human promyelocytic leukemic HL60 cells. Ohguchi, K., Banno, Y., Nakashima, S., Kato, N., Watanabe, K., Lyerly, D.M., Nozawa, Y. Infect. Immun. (1996)
- Induction of a 26-kDa-protein mRNA in human cells treated with an interleukin-1-related, leukocyte-derived factor. Content, J., De Wit, L., Poupart, P., Opdenakker, G., Van Damme, J., Billiau, A. Eur. J. Biochem. (1985)
- Impact of del32-71-GH (exon 3 skipped GH) on intracellular GH distribution, secretion and cell viability: a quantitative confocal microscopy analysis. Salemi, S., Yousefi, S., Eblé, A., Deladoëy, J., Mullis, P.E. Horm. Res. (2006)
- A defective signal peptide in the maize high-lysine mutant floury 2. Coleman, C.E., Lopes, M.A., Gillikin, J.W., Boston, R.S., Larkins, B.A. Proc. Natl. Acad. Sci. U.S.A. (1995)
- Ca(++)-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. Salzer, U., Hinterdorfer, P., Hunger, U., Borken, C., Prohaska, R. Blood (2002)
- Expression and clinical implication of soluble resistance-associated calcium-binding protein gene and multi-drug resistance gene in leukemia. Li, G., Tan, Y., Yang, C., Zhao, C., Zhao, H., Wang, J., Xue, Y., Han, M., Qian, L., Zhao, C. Zhonghua Zhong Liu Za Zhi (2002)
- Presenilin 2 regulates the systolic function of heart by modulating Ca2+ signaling. Takeda, T., Asahi, M., Yamaguchi, O., Hikoso, S., Nakayama, H., Kusakari, Y., Kawai, M., Hongo, K., Higuchi, Y., Kashiwase, K., Watanabe, T., Taniike, M., Nakai, A., Nishida, K., Kurihara, S., Donoviel, D.B., Bernstein, A., Tomita, T., Iwatsubo, T., Hori, M., Otsu, K. FASEB J. (2005)